HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US COVID-19 Fraud: Home-Use Fingerstick Collection Kits Promised Results Within 72 Hours

Executive Summary

FDA warns Florida firm Modern Allergy Management and a testing lab abut an unapproved and mislabeled home-use fingerstick sample collection for COVID-19 test. The firm promised results within three days.

You may also be interested in...



US FDA Finds Four More Firms Selling Unapproved COVID-19 Tests OTC, Including Stool Sample Kit

One stool sample kit and three serology tests are identified in the agency’s latest warning on OTC sales of unapproved COVID-19 tests. One of the warned firm continues offering sales of its violative product.

FDA Prioritizes Emergency-Use Reviews For Coronavirus At-Home Tests, Doubles Review Staff

A top FDA official said the agency has more than doubled its virology review staff to handle the cascade of EUA applications. He said the agency is prioritizing certain COVID-19 diagnostics during a recent webinar.

US COVID-19 Fraud: Licorice Promoted As Treatment, Unapproved Tests Offered OTC

FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150203

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel